TP53 and neoplasm: In conclusion, the tumor-only NGS assay yielded a number of possible SFs in TP53; however, the significance of additional germline testing for TP53 variants appears fairly low in daily clinical practice using a tumor-only NGS assay, unless patients report any relevant medical or family histories.